Literature DB >> 11891070

Effect of vehicles and penetration enhancers on the in vitro percutaneous absorption of tenoxicam through hairless mouse skin.

Hye Sun Gwak1, In Koo Chun.   

Abstract

The effects of vehicles and penetration enhancers on the in vitro permeation of tenoxicam from saturated solutions through dorsal hairless mouse skin were investigated. Various types of vehicles, including ester-, alcohol-, and ether-types and their mixtures, were used as vehicles, and then a series of fatty acids and amines were employed as enhancers, respectively. Even though the fluxes of tenoxicam from saturated pure vehicles were generally low (0.1-1.1 microg/cm2 per h), the skin permeability of tenoxicam was significantly increased by the combination of diethylene glycol monoethyl ether (DGME) and propylene glycol monolaurate (PGML) or propylene glycol monocaprylate (PGMC); the highest fluxes were achieved at 40% of DGME in both of the two cosolvents. The marked synergistic enhancement was also obtained by using propylene glycol (PG)-oleyl alcohol (OAl) cosolvent. The greatest flux was attained by the addition of unsaturated fatty acids at 3% concentration to PG. But saturated fatty acids failed to show a significant enhancing effect. The enhancement factors with the addition of oleic acid (OA) or linoleic acid (LOA) to PG were 348 and 238, respectively. Tromethamine (TM) showed an enhancing effect by the increased solubility; however, triethanolamine (TEA) did not show a significant enhancing effect. Rather, it decreased the fluxes of tenoxicam when added to PG with fatty acids. The above results indicate that the combinations of lipophilic vehicles like OA, LOA or OAl and hydrophilic vehicles like PG can be used for enhancing the skin permeation of tenoxicam.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11891070     DOI: 10.1016/s0378-5173(02)00009-1

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  12 in total

1.  In vitro percutaneous permeation and skin accumulation of finasteride using vesicular ethosomal carriers.

Authors:  Yuefeng Rao; Feiyue Zheng; Xingguo Zhang; Jianqing Gao; Wenquan Liang
Journal:  AAPS PharmSciTech       Date:  2008-07-23       Impact factor: 3.246

2.  A novel transdermal delivery system for the anti-inflammatory lumiracoxib: influence of oleic acid on in vitro percutaneous absorption and in vivo potential cutaneous irritation.

Authors:  Tailane Sant'Anna Moreira; Valéria Pereira de Sousa; Maria Bernadete Riemma Pierre
Journal:  AAPS PharmSciTech       Date:  2010-04-07       Impact factor: 3.246

3.  Formulation and Evaluation of Eudragit® RL Polymeric Double Layer Films for Prolonged-Release Transdermal Delivery of Tamsulosin Hydrochloride.

Authors:  Shereen M Assaf; Aya M Ghanem; Shayma'a A Alhaj; Enam A Khalil; AlSayed Alarabi Sallam
Journal:  AAPS PharmSciTech       Date:  2022-07-29       Impact factor: 4.026

4.  Development of w/o microemulsion for transdermal delivery of iodide ions.

Authors:  Hao Lou; Ni Qiu; Catherine Crill; Richard Helms; Hassan Almoazen
Journal:  AAPS PharmSciTech       Date:  2012-12-19       Impact factor: 3.246

5.  Amphiphilic star-like macromolecules as novel carriers for topical delivery of nonsteroidal anti-inflammatory drugs.

Authors:  Jelena Djordjevic; Bozena Michniak; Kathryn E Uhrich
Journal:  AAPS PharmSci       Date:  2003-10-16

6.  Development of lapachol topical formulation: anti-inflammatory study of a selected formulation.

Authors:  Ana Amélia M Lira; Elizângela A Sester; André Luis M Carvalho; Ruth R Strattmann; Miracy M Albuquerque; Almir G Wanderley; Davi P Santana
Journal:  AAPS PharmSciTech       Date:  2008-01-25       Impact factor: 3.246

7.  Comparison of the effect of tromethamine and polyvinylpyrrolidone on dissolution properties and analgesic effect of nimesulide.

Authors:  Hamdy Abdelkader; Ossama Y Abdallah; Hesham S Salem
Journal:  AAPS PharmSciTech       Date:  2007-08-10       Impact factor: 3.246

8.  An in-vitro-in-vivo model for the transdermal delivery of cholecalciferol for the purposes of rodent management.

Authors:  J Davies; A Ingham
Journal:  Int J Pharm       Date:  2015-03-30       Impact factor: 5.875

9.  Structure Enhancement Relationship of Chemical Penetration Enhancers in Drug Transport across the Stratum Corneum.

Authors:  Doungdaw Chantasart; S Kevin Li
Journal:  Pharmaceutics       Date:  2012-01-17       Impact factor: 6.321

10.  Enhancing the in vivo transdermal delivery of gold nanoparticles using poly(ethylene glycol) and its oleylamine conjugate.

Authors:  Pa Fan Hsiao; Sydney Peng; Ting-Cheng Tang; Shuian-Yin Lin; Hsieh-Chih Tsai
Journal:  Int J Nanomedicine       Date:  2016-05-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.